OhioHealth Robotic Urologic and Cancer Surgery, OhioHealth Dublin Methodist Hospital, Dublin, OH, USA.
BJU Int. 2020 Aug;126(2):259-264. doi: 10.1111/bju.15089. Epub 2020 May 19.
To demonstrate how using a standardised dosing strategy of indocyanine green (ICG) dye with near-infrared fluorescence (NIRF) imaging can be used to differentiate renal tumours from normal renal parenchyma during robot-assisted partial nephrectomy (RAPN).
We reviewed a prospectively collected database of 361 consecutive RAPNs using NIRF between June 2011 and March 2018, and determined the rate at which differential fluorescence was achieved. Tumour and kidney fluorescence or afluorescence were recorded intraoperatively and compared to histological results on final pathology.
Of 330 tumours, after 31 exclusions for nonvisible tumours due to adherent fat, completely intrarenal location or for incomplete data, 288 (87.3%) successfully exhibited differential fluorescence. Among the predominant histologies, 249 of 277 (89.9%) renal cell carcinomas did not fluoresce, as well as 23 of 32 (71.9%) oncocytomas. Real-time gross assessment of resection margin for fluorescence yielded a positive margin rate on final pathology of 0.30%.
When administered with a standardised ICG-dosing strategy, NIRF successfully achieved differential fluorescence in a large majority of tumours during RAPN with an exceedingly low positive margin rate.
展示如何使用标准化的吲哚菁绿(ICG)染料剂量策略与近红外荧光(NIRF)成像相结合,在机器人辅助部分肾切除术(RAPN)期间区分肾肿瘤与正常肾实质。
我们回顾了 2011 年 6 月至 2018 年 3 月期间使用 NIRF 进行的 361 例连续 RAPN 的前瞻性数据库,并确定了实现差异荧光的比率。术中记录肿瘤和肾脏荧光或荧光,并与最终病理的组织学结果进行比较。
在由于粘连脂肪、完全肾内位置或数据不完整而排除 330 个肿瘤中的 31 个非可见肿瘤后,288 个(87.3%)肿瘤成功显示出差异荧光。在主要组织学中,277 个肾细胞癌中的 249 个(89.9%)没有荧光,32 个嗜酸细胞瘤中的 23 个(71.9%)也没有荧光。实时评估切除边缘的荧光在最终病理上的阳性边缘率为 0.30%。
当使用标准化的 ICG 剂量策略时,NIRF 在 RAPN 期间成功地在绝大多数肿瘤中实现了差异荧光,并且阳性边缘率极低。